Aspira Women's Health Inc.
Company Information
Industry
In Vitro & In Vivo Diagnostic Substances
SIC Code
2835
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN, TX, 78738
Mailing Address
12117 BEE CAVES ROAD BUILDING THREE, AUSTIN, TX, 78738
Phone
512-519-0400
Fiscal Year End
1231
EIN
330595156
Financial Overview
FY2025 FY
$343K
Revenue
-$2.56M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 1, 2026 | View on SEC |
| 8-K/A Current report amendment | March 25, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 8-K Current report of material events | December 31, 2025 | View on SEC |
| S-1 IPO registration statement | December 31, 2025 | View on SEC |
| 8-K Current report of material events | December 23, 2025 | View on SEC |
| 8-K Current report of material events | December 22, 2025 | View on SEC |
| 4 Insider stock transaction report | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 4, 2025 | View on SEC |
| 4 Insider stock transaction report | December 3, 2025 | View on SEC |
Annual Reports
10-K
April 1, 2026
- Proprietary AI-powered diagnostic technology for ovarian cancer risk assessment.
- Pipeline expansion into endometriosis and genetic cancer risk testing.
Related Companies
Companies in the same industry (SIC: 2835)
VOLITIONRX LTD
VNRX
In Vitro & In Vivo Diagnostic Substances
IMMUCELL CORP /DE/
ICCC
In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX
In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV
In Vitro & In Vivo Diagnostic Substances
Q/C TECHNOLOGIES, INC.
QCLS
In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.